Galapagos' BioFocus Business Extends Contract with Amgen

The extension calls for the use of BioFocus' target discovery platform to deliver novel targets in support of Amgen's therapeutic programs.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.